With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.
A new study from the Advocate Aurora Research Institute - which is part of Advocate Health - published Tuesday in Hospital Pediatrics provides guidance for families and physicians caring for infants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results